Citadel Advisors’s GeoVax Labs GOVX Stock Holding History

Citadel Advisors’s Portfolio GOVX Stock Details GOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-24,615	Closed	-$105K	–	13456
2025 Q4	$105K	Buy	+24,615	New	+$271K	﹤0.01%	11601
2025 Q1	–	Sell	-1,691	Closed	-$104K	–	14893
2024 Q4	$104K	Buy	+1,691	New	+$97.9K	﹤0.01%	11426
2022 Q2	–	Sell	-44	Closed	-$19K	–	13323
2022 Q1	$19K	Buy	+44	New	+$35K	﹤0.01%	13256
2021 Q3	–	Sell	-40	Closed	-$75K	–	14104
2021 Q2	$75K	Sell	40 -161	-80%	-$313K	﹤0.01%	13115
2021 Q1	$330K	Buy	+201	New	+$391K	﹤0.01%	10615

Other funds holding GOVX

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors's GOVX Position: Q1 2026 in Review

Citadel Advisors sold out of GeoVax Labs (GOVX) in Q1 2026, closing a stake of 24,615 shares — an estimated $105K sold.

Citadel Advisors first reported a position in GOVX in Q1 2021 and held it in 5 quarters. The position peaked at $330K in Q1 2021. 16 funds tracked by Wall St. Rank hold GOVX as of Q1 2026.

Citadel Advisors reported no remaining GeoVax Labs position as of Q1 2026 after selling out during the quarter.
Citadel Advisors sold 24,615 GeoVax Labs shares in Q1 2026, an estimated $105K.
Citadel Advisors first reported a position in GeoVax Labs in Q1 2021 and held it in 5 quarters.
Citadel Advisors's GeoVax Labs position peaked at $330K in Q1 2021.
16 funds tracked by Wall St. Rank held GeoVax Labs as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.